The homeodomain region controls the phenotype of HOX-induced murine leukemia

Blood

Volumn 120, Issue 19, 2012, Pages 4018-4027

  Breitinger, Constanze ^a   Maethner, Emanuel ^a   Garcia Cuellar, Maria Paz ^a   Slany, Robert K ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR PBX; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LEUKEMOGENESIS; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION;

EID: 84868607120     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-384685     Document Type: Article

References (52)

1. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene. 2007;26(47):6766-6776. (Pubitemid 47585101)
2. Eklund EA. The role of HOX genes in malignant myeloid disease. Curr Opin Hematol. 2007;14(2): 85-89. (Pubitemid 46175091)
3. Thorsteinsdottir U, Sauvageau G, Humphries RK. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol Oncol Clin North Am. 1997;11(6):1221-1237. (Pubitemid 28028699)
4. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286(5439):531-537.
5. Soulier J, Clappier E, Cayuela JM, et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (TALL). Blood. 2005;106(1):274-286. (Pubitemid 40967203)
6. Speleman F, Cauwelier B, Dastugue N, et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia. 2005;19(3):358-366. (Pubitemid 40403311)
7. Nakamura T. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins. Int J Hematol. 2005;82(1):21-27. (Pubitemid 41512194)
8. Hess JLMLL: a histone methyltransferase disrupted in leukemia. Trends Mol Med. 2004; 10(10):500-507.
9. Slany RK. The molecular biology of mixed lineage leukemia. Haematologica. 2009;94(7):984-993.
10. Smith E, Lin C, Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 2011;25(7):661-672.
11. Bansal D, Scholl C, Frohling S, et al. Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model. Proc Natl Acad Sci U S A. 2006;103(45):16924-16929. (Pubitemid 44737354)
12. Rawat VP, Cusan M, Deshpande A, et al. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12; 13)(p13;q12) acute myeloid leukemia. Proc Natl Acad Sci U S A. 2004;101(3):817-822. (Pubitemid 38121041)
13. Rawat VP, Thoene S, Naidu VM, et al. Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. Blood. 2008;111(1):309-319.
14. Thoene S, Rawat VP, Heilmeier B, et al. The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia. Leukemia. 2009;23(4):649-655.
15. Ito T, Kwon HY, Zimdahl B, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 2010;466(7307):765-768.
16. Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471(7339):467-472.
17. Schnabel CA, Jacobs Y, Cleary ML. HoxA9- mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis. Oncogene. 2000;19(5):608- 616.
18. Berger MF, Badis G, Gehrke AR, et al. Variation in homeodomain DNA binding revealed by highresolution analysis of sequence preferences. Cell. 2008;133(7):1266-1276. (Pubitemid 351852913)
19. Catron KM, Iler N, Abate C. Nucleotides flanking a conserved TAAT core dictate the DNA binding specificity of three murine homeodomain proteins. Mol Cell Biol. 1993;13(4):2354-2365. (Pubitemid 23097714)
20. Gehring WJ, Qian YQ, Billeter M, et al. Homeodomain-DNA recognition. Cell. 1994; 78(2):211-223. (Pubitemid 24241090)
21. Noyes MB, Christensen RG, Wakabayashi A, Stormo GD, Brodsky MH, Wolfe SA. Analysis of homeodomain specificities allows the family-wide prediction of preferred recognition sites. Cell. 2008;133(7):1277-1289. (Pubitemid 351852912)
22. Chang CP, Brocchieri L, Shen WF, Largman C, Cleary ML. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNAbinding specificities across the Hox locus. Mol Cell Biol. 1996;16(4):1734-1745. (Pubitemid 26095646)
23. Chang CP, Jacobs Y, Nakamura T, Jenkins NA, Copeland NG, Cleary ML. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins. Mol Cell Biol. 1997; 17(10):5679-5687. (Pubitemid 27411075)
24. Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev. 1995; 9(6):663-674.
25. Jacobs Y, Schnabel CA, Cleary ML. Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity. Mol Cell Biol. 1999;19(7):5134-5142. (Pubitemid 29289551)
26. Shen WF, Montgomery JC, Rozenfeld S, et al. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins. Mol Cell Biol. 1997;17(11):6448-6458. (Pubitemid 27451190)
27. Shen WF, Rozenfeld S, Kwong A, Kom ves LG, Lawrence HJ, Largman C. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol. 1999;19(4):3051-3061. (Pubitemid 29144550)
28. Nakamura T, Largaespada DA, Shaughnessy JD Jr, Jenkins NA, Copeland NG. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias. Nat Genet. 1996;12(2):149- 153.
29. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17(13):3714-3725. (Pubitemid 28327389)
30. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol. 2001;21(1):224-234.
31. Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 2007;21(21):2762-2774. (Pubitemid 350070722)
32. Calvo KR, Sykes DB, Pasillas M, Kamps MP. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol. 2000; 20(9):3274-3285. (Pubitemid 30215039)
33. Calvo KR, Sykes DB, Pasillas MP, Kamps MP. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral coexpression of Hoxa9 and Meis1. Oncogene. 2002;21(27):4247-4256. (Pubitemid 34753831)
34. Bach C, Buhl S, Mueller D, Garcia-Cuellar MP, Maethner E, Slany RK. Leukemogenic transformation by HOXA cluster genes. Blood. 2010; 115(14):2910-2918.
35. Hawley RG, Sabourin LA, Hawley TS. An improved retroviral vector for gene transfer into undifferentiated cells. Nucleic Acids Res. 1989; 17(10):4001. (Pubitemid 19153400)
36. Sadowski I, Ptashne M. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 1989;17(18):7539. (Pubitemid 19242345)
37. Swift S, Lorens J, Achacoso P, Nolan GP. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol. 2001;Chapter 10:Unit 10.17C.
38. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16(14):4226- 4237.
39. Zeisig BB, So CW. Retroviral/lentiviral transduction and transformation assay. Methods Mol Biol. 2009;538:207-229.
40. LaRonde-LeBlanc NA, Wolberger C. Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. Genes Dev. 2003;17(16):2060-2072. (Pubitemid 36999331)
41. Hess JL, Bittner CB, Zeisig DT, et al. c-Myb is an essential downstream target for homeoboxmediated transformation of hematopoietic cells. Blood. 2006;108(1):297-304. (Pubitemid 43990642)
42. Phelan ML, Rambaldi I, Featherstone MS. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif. Mol Cell Biol. 1995;15(8):3989-3997.
43. Remacle S, Abbas L, De Backer O, et al. Loss of function but no gain of function caused by amino acid substitutions in the hexapeptide of Hoxa1 in vivo. Mol Cell Biol. 2004;24(19):8567-8575. (Pubitemid 39245077)
44. Chen J, Ruley HE. An enhancer element in the EphA2 (Eck) gene sufficient for rhombomerespecific expression is activated by HOXA1 and HOXB1 homeobox proteins. J Biol Chem. 1998; 273(38):24670-24675. (Pubitemid 28454966)
45. Wang GG, Pasillas MP, Kamps MP. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol. 2006;26(10):3902-3916. (Pubitemid 43726406)
46. Chan SK, Mann RS. The segment identity functions of Ultrabithorax are contained within its homeo domain and carboxy-terminal sequences. Genes Dev. 1993;7(5):796-811. (Pubitemid 23163584)
47. Gibson G, Schier A, LeMotte P, Gehring WJ. The specificities of Sex combs reduced and Antennapedia are defined by a distinct portion of each protein that includes the homeodomain. Cell. 1990;62(6):1087-1103.
48. Mann RS, Lelli KM, Joshi R. Hox specificity unique roles for cofactors and collaborators. Curr Top Dev Biol. 2009;88:63-101.
49. Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005;106(1):254-264. (Pubitemid 40967201)
50. Shanmugam K, Green NC, Rambaldi I, Saragovi HU, Featherstone MS. PBX and MEIS as non-DNAbinding partners in trimeric complexes with HOX proteins. Mol Cell Biol. 1999;19(11):7577-7588. (Pubitemid 29493421)
51. Argiropoulos B, Yung E, Xiang P, et al. Linkage of the potent leukemogenic activity of Meis1 to cellcycle entry and transcriptional regulation of cyclin D3. Blood. 2010;115(20):4071-4082.
52. Mamo A, Krosl J, Kroon E, et al. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. Blood. 2006;108(2):622-629. (Pubitemid 44061363)